Noticias de SNGX_US

Noticias del mercado

Últimas noticias sobre SNGX_US — 38 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SNGX_US ✕ 38 resultados
30/03/2026 SNGX_US — marketscreener.com
Soligenix, Inc. Auditor Raises 'Going Concern' Doubt
26/03/2026 SNGX_US — Quantisnow
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
26/03/2026 SNGX_US — Investing.com ES ← EN
Soligenix recibe el estatus de medicamento huérfano de la UE para el tratamiento de Behçet
23/03/2026 SNGX_US — Benzinga ES ← EN
Soligenix (NASDAQ: SNGX) fortalece el programa de desarrollo de enfermedades raras a través del diseño de innovación regulatoria del Reino Unido
23/03/2026 SNGX_US — Yahoo Finance
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
19/03/2026 SNGX_US — The Globe and Mail
Soligenix (NASDAQ: SNGX) Highlights HyBryte Clinical Data in Peer-Reviewed Journal Publication
19/03/2026 SNGX_US — Yahoo Finance
Soligenix (SNGX) Highlights HyBryte Clinical Data in Peer-Reviewed Journal Publication
19/03/2026 SNGX_US — The Manila Times
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
19/03/2026 SNGX_US — PR Newswire
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
19/03/2026 SNGX_US — Yahoo Finance
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
12/03/2026 SNGX_US — Yahoo Finance ES ← EN
SNGX: Próximas lecturas importantes en el estudio CTCL de fase 3
10/03/2026 SNGX_US — PR Newswire
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
10/03/2026 SNGX_US — Investing.com
Soligenix receives UK regulatory designation for Behçet’s drug
26/02/2026 SNGX_US — Investing.com
Soligenix receives positive EMA opinion for orphan drug status
25/02/2026 SNGX_US — Intellectia AI
SNGX Should I Buy
24/02/2026 SNGX_US — PR Newswire
Soligenix to Present at BIO Investment & Growth Summit
12/02/2026 SNGX_US — Financial Times
Soligenix Details Recent Progress and Upcoming Milestones – Company Announcement
12/02/2026 SNGX_US — PR Newswire
Soligenix Details Recent Progress and Upcoming Milestones

Página 2 de 2

keyboard_arrow_up